Ethics in international health research: a perspective from the developing world.

Health research plays a pivotal role in addressing inequities in health and human development, but to achieve these objectives the research must be based on sound scientific and ethical principles. Although it is accepted that ethics play a central role in health research in developing countries, much of the recent debate has focused on controversies surrounding internationally sponsored research and has taken place largely without adequate participation of the developing countries. The relationship between ethical guidelines and regulations, and indigenously sponsored and public health research has not been adequately explored. For example, while the fundamental principles of ethical health research, such as community participation, informed consent, and shared benefits and burdens, remain sacrosanct other issues, such as standards of care and prior agreements, merit greater public debate within developing countries. In particular, the relationship of existing ethical guidelines to epidemiological and public health research merits further exploration. In order to support health research in developing countries that is both relevant and meaningful, the focus must be on developing health research that promotes equity and on developing local capacity in bioethics. Only through such proactive measures can we address the emerging ethical dilemmas and challenges that globalization and the genomics revolution will bring in their wake.

[1]  B. Pasamanick,et al.  Experiments at Willowbrook. , 1971, The Lancet.

[2]  M. Angell The ethics of clinical research in the Third World. , 1997, The New England journal of medicine.

[3]  J. Sterne,et al.  Child mortality following standard, medium or high titre measles immunization in West Africa. , 1996, International journal of epidemiology.

[4]  D. Wendler Informed consent, exploitation and whether it is possible to conduct human subjects research without either one. , 2000, Bioethics.

[5]  S. Krugman Experiments at the Willowbrook State School. , 1971, Lancet.

[6]  A. Brandt,et al.  Racism and research: the case of the Tuskegee Syphilis Study. , 1978, The Hastings Center report.

[7]  Glass At Photodynamic therapy for bladder cancer: ethics of a collaborative trial in China. , 1988 .

[8]  T. Edejer North-South research partnerships: the ethics of carrying out research in developing countries , 1999, BMJ.

[9]  A. Fairchild,et al.  Uses and Abuses of Tuskegee , 1999, Science.

[10]  Claire Gilbert Foster,et al.  International ethical guidelines for biomedical research involving human subjects , 1994 .

[11]  M. Angell Ethical imperialism? Ethics in international collaborative clinical research. , 1988, The New England journal of medicine.

[12]  A. Hyder,et al.  Health ethics in Pakistan: a literature review of its present state. , 2001, Journal of health, population, and nutrition.

[13]  The ethics industry , 1997, The Lancet.

[14]  L. Smeeth Poverty, inequality and health , 2001 .

[15]  J. Mackenbach,et al.  World Health Report 2000: inequality index and socioeconomic inequalities in mortality , 2001, The Lancet.

[16]  S. Benatar Global disparities in health and human rights: a critical commentary. , 1998, American journal of public health.

[17]  Gambia GovernmentMedical Research Council Joint Ethical Committee Ethical issues facing medical research in developing countries , 1998, The Lancet.

[18]  D. Rothman Were Tuskegee & Willowbrook 'studies in nature'? , 1982, The Hastings Center report.

[19]  Z. Bhutta,et al.  Is management of neonatal respiratory distress syndrome feasible in developing countries? Experience from Karachi (Pakistan) , 1999, Pediatric pulmonology.

[20]  U. d’Alessandro,et al.  Editorial: The 5th Amendment of the Declaration of Helsinki: implications for medical research in developing countries , 2001 .

[21]  S. Jaffar,et al.  Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants , 1997, The Lancet.

[22]  Robert N. Proctor,et al.  Factories of Death: Japanese Biological Warfare, 1932-45, and the American Cover-up , 1996 .

[23]  Y. Kluger,et al.  Diarrheal epidemics among Rwandan refugees in 1994. Management and outcome in a field hospital. , 1997, Journal of clinical gastroenterology.

[24]  R. Macklin Informed consent for research: international perspectives. , 2000, Journal of the American Medical Women's Association.

[25]  R. Fish,et al.  The standard of care. , 1994, The Journal of emergency medicine.

[26]  C. Grady Science in the service of healing. , 1998, The Hastings Center report.

[27]  K. Hedayat,et al.  Issues in Islamic biomedical ethics: a primer for the pediatrician. , 2001, Pediatrics.

[28]  A. London The ambiguity and the exigency: clarifying 'standard of care' arguments in international research. , 2000, The Journal of medicine and philosophy.

[29]  R. Gelber,et al.  "Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type I with Zidovudine Treatment." , 1994 .

[30]  Z. Bhutta Why has so little changed in maternal and child health in south Asia? , 2000, BMJ : British Medical Journal.

[31]  U. Schuklenk Protecting the vulnerable: testing times for clinical research ethics. , 2000, Social science & medicine.

[32]  R. Semba Ethics of HIV trials , 1997, The Lancet.

[33]  M. Whitehead,et al.  Challenging inequities in health: from ethics to action. , 2001 .

[34]  J. Moreno Reassessing the influence of the Nuremberg Code on American medical ethics. , 1997, The Journal of contemporary health law and policy.

[35]  Allyson M Pollock,et al.  How the World Trade Organisation is shaping domestic policies in health care , 1999, The Lancet.

[36]  A. Wakhweya Structural adjustment and health , 1995, BMJ.

[37]  P. Lurie,et al.  Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. , 1997, The New England journal of medicine.

[38]  R. Redfield,et al.  The serological markers of hepatitis A and B in healthy population in northern Pakistan. , 1988, JPMA. The Journal of the Pakistan Medical Association.

[39]  I. Kickbusch The development of international health policies--accountability intact? , 2000, Social science & medicine.

[40]  T. Faunce,et al.  Trade Related Aspects of Intellectual Property Rights (TRIPS) and the Threat to Patients: A Plea for Doctors to Respond Internationally , 1998, Medicine and law : an international journal.

[41]  A. Hyder Challenging Inequities in Health: From Ethics to Action , 2002 .

[42]  Lincoln C. Chen,et al.  Health Equity in a Globalizing World , 2001 .

[43]  S. Burger An Introduction to the Study of Experimental Medicine , 1950, The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha.

[44]  C. Foster,et al.  International ethical guidelines for biomedical research involving human subjects , 1994, Bulletin of medical ethics.

[45]  R. Macklin After Helsinki: Unresolved Issues in International Research , 2001, Kennedy Institute of Ethics journal.

[46]  M. Roberts,et al.  Ethical analysis in public health , 2002, The Lancet.

[47]  D. Rothman The shame of medical research. , 2000, The New York review of books.

[48]  D. Resnik The ethics of HIV research in developing nations. , 1998, Bioethics.

[49]  S S Ellenberg,et al.  Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 1: Ethical and Scientific Issues , 2000, Annals of Internal Medicine.

[50]  M. Barry Ethical considerations of human investigation in developing countries: the AIDS dilemma. , 1988, The New England journal of medicine.

[51]  P. Singer,et al.  Beyond Helsinki: a vision for global health ethics , 2001, BMJ : British Medical Journal.

[52]  Bhutta Za Beyond the millennium: What can be done to improve child health in South Asia? [editorial] , 2001 .

[53]  Rochelle Furstenberg,et al.  MEDICAL ETHICS , 1954 .

[54]  B. Bloom The Highest Attainable Standard: Ethical Issues in AIDS Vaccines , 1998, Science.

[55]  B. Schwartz,et al.  Intussusception among infants given an oral rotavirus vaccine. , 2001, The New England journal of medicine.

[56]  T. Evans,et al.  Ethical dimensions of health equity , 2001 .

[57]  福永 幹彦 Hrobjartsson A, Gotzsche PC : Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment , 2002 .

[58]  H. Jonas Philosophical Reflections on Experimenting with Human Subjects , 1979 .

[59]  A. Costello,et al.  Moving to research partnerships in developing countries , 2000, BMJ : British Medical Journal.

[60]  S. Ramsay WMA postpones decision to revise Declaration of Helsinki , 1999, The Lancet.

[61]  C. Levine Placebos and HIV. Lessons learned. , 1998, The Hastings Center report.

[62]  F. Collins,et al.  Shattuck lecture--medical and societal consequences of the Human Genome Project. , 1999, The New England journal of medicine.

[63]  J. Arras,et al.  AZT trials and tribulations. , 1998, The Hastings Center report.

[64]  J. Mann Leadership is a global issue , 1997, The Lancet.

[65]  H. Greely Human Genomics Research: New Challenges for Research Ethics , 2001, Perspectives in biology and medicine.

[66]  J. Shiloach,et al.  The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. , 2001, The New England journal of medicine.

[67]  Z. Bhutta Structural adjustments and their impact on health and society: a perspective from Pakistan. , 2001, International journal of epidemiology.

[68]  Health systems: improving performance , 2000 .

[69]  T. Brennan Proposed revisions to the Declaration of Helsinki--will they weaken the ethical principles underlying human research? , 1999, The New England journal of medicine.

[70]  R. Levine The “Best Proven Therapeutic Method” Standard in Clinical Trials in Technologically Developing Countries , 1998, The Journal of Clinical Ethics.

[71]  J. Omene Science, ethics, and future of research into maternal-infant transmission of HIV-1 , 1999, The Lancet.

[72]  Z. Bankowski,et al.  Council for International Organizations of Medical Sciences , 1991 .

[73]  D. Etya’ale,et al.  Mectizan as a stimulus for development of novel partnerships: the international organization's perspective. , 1998, Annals of tropical medicine and parasitology.

[74]  Z. Bhutta Beyond the millennium: what can be done to improve child health in South Asia? , 2001, Indian pediatrics.

[75]  S. Krugman,et al.  Relation of Australia-SH antigen to the willowbrook MS-2 strain. , 1969, The New England journal of medicine.

[76]  A. Sommer,et al.  Ethics and international research , 1997, BMJ.

[77]  S. Ravenscroft,et al.  Cultural and Ethical Relativism , 1991 .

[78]  K. Warren Research in developing countries , 1992, The Lancet.

[79]  J. Mann Public health. Leadership is a global issue. , 1997, Lancet.

[80]  E. Pellegrino,et al.  Clinical ethics revisited , 2001, BMC medical ethics.

[81]  R. Levine,et al.  Some Recent Developments in the International Guidelines on the Ethics of Research Involving Human Subjects a , 2000, Annals of the New York Academy of Sciences.

[82]  N. Kass An ethics framework for public health. , 2001, American journal of public health.

[83]  C. Olweny Bioethics in developing countries: ethics of scarcity and sacrifice. , 1994, Journal of medical ethics.

[84]  R. Ashcroft,et al.  International Research Ethics , 2000, Bioethics.

[85]  D. Greco Science, ethics, and future of research into maternal-infant transmission of HIV-1 , 1999, The Lancet.

[86]  R. Morrison,et al.  Effect of home-based neonatal care and management of sepsis on neonatal mortality: field trial in rural India , 1999, The Lancet.

[87]  G. Annas,et al.  Research in developing countries: taking "benefit" seriously. , 1998, The Hastings center report.

[88]  Z. Ullah,et al.  Prevalence of hepatitis-B antigen in various population groups of N.W.F.P. , 1980, JPMA. The Journal of the Pakistan Medical Association.

[89]  S. Plattner,et al.  National Bioethics Advisory Commission , 2001 .

[90]  R. Levine,et al.  The need to revise the Declaration of Helsinki. , 1999, The New England journal of medicine.

[91]  Ethics of HIV trials , 1997 .

[92]  J. Barendregt,et al.  Global burden of disease , 1997, The Lancet.

[93]  A. Daar,et al.  Harnessing Genomics and Biotechnology to Improve Global Health Equity , 2001, Science.

[94]  D. Greco Revising the declaration of Helsinki: ethics vs economics or the fallacy of urgency. , 2000, Canadian HIV/AIDS policy & law review.

[95]  D. Guenter,et al.  Ethical considerations in international HIV vaccine trials: summary of a consultative process conducted by the Joint United Nations Programme on HIV/AIDS (UNAIDS) , 2000, Journal of medical ethics.

[96]  L. Roberts,et al.  Clinical ethics revisited: responses , 2001, BMC medical ethics.

[97]  S. Ellenberg,et al.  Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 2: Practical Issues and Specific Cases , 2000, Annals of Internal Medicine.

[98]  B. Freedman Equipoise and the ethics of clinical research. , 1987, The New England journal of medicine.

[99]  R. Snow,et al.  Will reducing Plasmodium falciparum transmission alter malaria mortality among african children , 1995 .

[100]  M. Ainsworth,et al.  Breaking the silence: setting realistic priorities for AIDS control in less-developed countries , 2000, The Lancet.

[101]  N. Nagelkerke,et al.  Impact of user fees on attendance at a referral centre for sexually transmitted diseases in Kenya , 1992, The Lancet.

[102]  E. Shuster Fifty years later: the significance of the Nuremberg Code. , 1997, The New England journal of medicine.

[103]  H. Heimlich,et al.  Malariotherapy for HIV patients , 1997, Mechanisms of Ageing and Development.

[104]  E. Emanuel,et al.  Protecting Communities in Biomedical Research , 2000, Science.

[105]  D. Yach,et al.  The globalization of public health, I: Threats and opportunities. , 1998, American journal of public health.

[106]  D. Mahalanabis,et al.  Oral fluid therapy of cholera among Bangladesh refugees. , 1973, The Johns Hopkins medical journal.

[107]  Defining a new bioethic , 2001, Nature Genetics.

[108]  H. Varmus,et al.  Ethical complexities of conducting research in developing countries. , 1997, The New England journal of medicine.

[109]  S. Eckstein Operational guidelines for ethics committees that review biomedical research , 2003 .

[110]  S. Jaffar,et al.  Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants. , 1997, Lancet.

[111]  D. Thomasma Bioethics and International Human Rights , 1997, Journal of Law, Medicine & Ethics.

[112]  J. Mann Medicine and public health, ethics and human rights. , 1997, The Hastings Center report.

[113]  Jeremy Bentham,et al.  The Principles of Morals and Legislation , 1988 .

[114]  S. Davey,et al.  The 10/90 report on health research 2003-2004. , 2004 .

[115]  Sheldon H. Harris Notorious Events. (Book Reviews: Factories of Death. Japanese Biological Warfare 1932-45 and the American Cover-Up) , 1993 .

[116]  G. Annas,et al.  Human rights and maternal-fetal HIV transmission prevention trials in Africa. , 1998, American journal of public health.

[117]  M. Koivusalo,et al.  The World Health Report 2000 , 2002 .

[118]  N. Rollins,et al.  Current controversies in the perinatal transmission of HIV in developing countries , 1999 .

[119]  R. W. Mccollum Viral Hepatitis , 1969, JAMA.

[120]  S. Benatar,et al.  A new look at international research ethics , 2000, BMJ : British Medical Journal.

[121]  J. Sachs,et al.  The geography of poverty and wealth. , 2001, Scientific American.

[122]  B. Crigger National Bioethics Advisory Commission Report: Ethical and policy issues in international research. , 2001, IRB.